Rare Neurological Disorder

• Business
• Education
• Healthcare
• Industrial
• Management
• Media
• News
• Pharma & Biotech
• Science
• Technology
• United Kingdom

Alexion to Present Data Reinforcing Effectiveness of Ultomiris and Soliris in Treating Rare Neurological Disorder at ECTRIMS-ACTRIMS Meeting

(IN BRIEF) Alexion, a subsidiary of AstraZeneca Rare Disease, is set to present new data at the 9th Joint Meeting…